Al-Matary et al. evaluated the role of TAMs in AML tumorigenesis and found that the frequency of CD163+CD206+ M2-like TAMs was significantly elevated in the BM of AML patients compared to healthy volunteers. The gene discussed is CD163; the disease is acute myeloid leukemia.